NCT01803425 Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka Status WITHDRAWN Phase N/A
NCT01803399 A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers Status WITHDRAWN Phase PHASE1
NCT01803074 Study to Evaluate a HIV Drug for the Treatment of HIV Infection Status COMPLETED Phase PHASE2
NCT01802918 Single Dose Escalation Study of GSK2838232 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01802892 Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret) Status COMPLETED Phase PHASE1
NCT01798992 Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart Status COMPLETED Phase PHASE4
NCT01798056 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT01797926 Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT01793870 A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies Status COMPLETED Phase PHASE1
NCT01793857 Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama Status COMPLETED Phase N/A
NCT01788813 To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies Status COMPLETED Phase PHASE2
NCT01788228 Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure Status COMPLETED Phase PHASE3
NCT01782794 Acceptability of Hepatitis B Vaccination in General Population Status COMPLETED Phase N/A
NCT01782664 A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01782651 Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients Status COMPLETED Phase N/A
NCT01777334 The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD Status COMPLETED Phase PHASE3
NCT01777321 Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years Status COMPLETED Phase PHASE3
NCT01777308 Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination Status COMPLETED Phase PHASE3